in

Study: Access to targeted lung cancer drug is cost-prohibitive globally

Study: Access to targeted lung cancer drug is cost-prohibitive globally

Median PFS (A) and OS (B) estimates, along with fitted piecewise exponential distributions, for each treatment arm used in the Markov model. Credit: JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2024.13938

Many countries with national health care systems or payers such as insurance companies use cost-effectiveness analyses to decide…


Posted by Editor

The finalists of the 2024 edition of the ANDAM award.

EXCLUSIVE: Christopher Esber, 3.Paradis and Meryll Rogge Among Finalists for ANDAM Fashion Awards

Close up of OnePlus Watch 2’s digital crown

The OnePlus Watch 2 broke the nerdy covenant that smartwatch crowns must scroll